Showing results (51-60 of 84) with videos related to

Sort By:
Pageof 9
Zhonghua Yi Xue Za Zhi|September 5, 2012
[Efficacy analysis of third-generation plus platinum doublets in the first-line chemotherapy of advanced non-small cell lung cancer]Ling-di Zhao, Xiang-ru Zhang, Jun-ling Li, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|September 13, 2012
[Evaluation of the role of rhIL-11 on hematological recovery in lymphoma patients after autologous hematopoietic stem cell transplantation]Jian-liang Yang, Yuan-kai Shi, Xiao-hui He, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|August 14, 2012
[Comparative analysis of liver function in HBsAg-/HBcAb+ patients with diffuse large B-cell lymphoma treated with CHOP and R-CHOP regimens]Yan-hua Huang, Xiao-hui He, Yan Qin, et al.
Journal of Thoracic Disease|July 10, 2019
Circular RNA profiling identified as a biomarker for predicting the efficacy of Gefitinib therapy for non-small cell lung cancerYu-Tao Liu, Xiao-Hong Han, Pu-Yuan Xing, et al.
AI Zheng = Aizheng = Chinese Journal of Cancer|April 12, 2005
[Treatment effect of DICE regimen on patients with relapsed or refractory intermediate and high grade non-Hodgkin's lymphoma]Sheng-Yu Zhou, Yuan-Kai Shi, Xiao-Hui He, et al.
AI Zheng = Aizheng = Chinese Journal of Cancer|October 6, 2009
[Efficacy of modified Hyper-CVAD regimen on non-Hodgkin's lymphoma and safety evaluation]Wei Shi, Yuan-Kai Shi, Xiao-Hui He, et al.
Thoracic Cancer|August 23, 2021
Circulating tumor cells (CTCs)/circulating tumor endothelial cells (CTECs) and their subtypes in small cell lung cancer: Predictors for response and prognosisHao-Hua Zhu, Yu-Tao Liu, Yu Feng, et al.
Cancer Chemotherapy and Pharmacology|February 25, 2012
Phase I study of chidamide (CS055/HBI-8000), a new histone deacetylase inhibitor, in patients with advanced solid tumors and lymphomasMei Dong, Zhi-Qiang Ning, Pu-Yuan Xing, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|April 17, 2003
[Middle-high dose of cyclophosphamide or conventional routine chemotherapy with increased dose of cyclophosphamide combined with G-CSF for mobilizing peripheral blood progenitor cells in patients with tumor]Dao-pei Lu, Kai-yan Liu, Nai-lan Guo, et al.
Chinese Medical Journal|December 1, 2016
Decreased Prognostic Value of International Prognostic Score in Chinese Advanced Hodgkin Lymphoma Patients Treated in the Contemporary EraQin Wang, Yan Qin, Su-Yi Kang, et al.
Pageof 9